July 17, 2019 11:16 AM ET

Capital Markets

Company Overview of Ladenburg Thalmann & Co. Inc.

Company Overview

Ladenburg Thalmann & Co. Inc. provides investment banking and securities brokerage services to middle-market and emerging growth companies. The firm offers public offerings, private placements, fairness and solvency opinions, and mergers and acquisitions advisory services. Additionally, it provides institutional equity sales and trading services. The firm is based in Miami, Florida. As of May 7, 2001, Ladenburg Thalmann & Co. Inc. operates as a subsidiary of Ladenburg Thalmann Financial Services Inc.

4400 Biscayne Boulevard

12th Floor

Miami, FL 33137

United States

Key Executives for Ladenburg Thalmann & Co. Inc.

Co-CEO & Co-President
Age: 62
Co-President & Co-CEO
Principal Financial Officer, CFO, Senior VP & Director
Age: 60
Managing Director
MD & Head of Capital Markets
Compensation as of Fiscal Year 2019.

Ladenburg Thalmann & Co. Inc. Key Developments

NeuroMetrix Is Considering Strategic Alternatives

NeuroMetrix, Inc. (NasdaqCM:NURO) announced that it has retained Ladenburg Thalmann & Co. Inc. as its financial advisor to explore strategic alternatives to enhance shareholder value, including the potential sale or merger of the company. There can be no assurance of a successful outcome from these efforts, or of the form or timing of such outcome.

Gemphire Therapeutics Inc. Engages Ladenburg Thalmann & Co. Inc. to Act as Strategic Financial Advisor to Review its Strategic Alternatives and Provides Corporate Update

Gemphire Therapeutics Inc. announced that its board of directors is conducting a review of a range of strategic alternatives focused on maximizing stockholder value. The company has engaged Ladenburg Thalmann & Co. Inc. to act as its strategic financial advisor for this process. The board of directors has established a committee to oversee this review.

Gemphire Therapeutics Announces Review Of Strategic Alternatives

Gemphire Therapeutics Inc. (NasdaqGM: GEMP) has announced that its Board of Directors is conducting a review of a range of strategic alternatives focused on maximizing stockholder value. Gemphire Therapeutics has engaged Ladenburg Thalmann & Co. Inc. to act as its strategic financial advisor for the process. The Board of Directors has established a committee to oversee the review. Potential strategic alternatives that may be evaluated include, but are not limited to, an acquisition, merger, business combination, in-licensing, or other strategic transaction involving Gemphire Therapeutics. There can be no assurance that the process will result in Gemphire pursuing any transaction or that any transaction, if pursued, will be completed. Gemphire Therapeutics does not intend to discuss or disclose further developments regarding the strategic review process unless and until its Board of Directors has approved a specific action or otherwise determined that further disclosure is appropriate or required by law.

Similar Private Companies By Industry

Company Name Region
The Wilcox Group, LLC United States
.Comdaq Corporation United States
.KOMM Investments, Ltd. United States
@Visory LLC United States
1 Road Partners LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
International Monetary Fund United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ladenburg Thalmann & Co. Inc., please visit www.ladenburg.com/services/ladenburg-thalmann-co-inc/investment-banking. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.